NASDAQ:FBIO - Nasdaq - US34960Q3074 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 62.50M | 84.51M | 75.74M | 68.79M | 45.60M | |||
Minority Interest Expense | 75.01M | 93.52M | 127.34M | 100.12M | 56.46M | |||
Cost Of Goods | 24.66M | 26.66M | 30.78M | 32.08M | 14.59M | |||
Gross Profit | 37.84M | 57.85M | 44.97M | 36.71M | 31.01M | |||
Operating Expenses | 141.30M | 197.09M | 248.53M | 215.71M | 125.28M | |||
Research and Development | 61.02M | 106.07M | 134.88M | 128.87M | 64.11M | |||
Selling, General, and Administrative Expenses | 80.28M | 91.02M | 113.66M | 86.84M | 61.17M | |||
Operating Income | -103.45M | -139.24M | -203.56M | -179.00M | -94.27M | |||
Interest Income/Expense | -10.71M | -12.31M | -11.20M | 24.19M | -8.58M | |||
Other Income/Expense | -6.31M | 4.42M | 1.30M | N/A | N/A | |||
Non Recurring Items | -2.61M | -6.50M | 0.00 | -9.54M | 0.00 | |||
Income Before Taxes | -123.08M | -153.63M | -213.46M | -164.35M | -102.85M | |||
Income Tax | N/A | 521.00K | 450.00K | 470.00K | 140.00K | |||
Net Income | -57.53M | -68.67M | -86.58M | -64.70M | -46.53M | |||
EBITDA | -98.92M | -133.25M | -196.17M | -173.90M | -90.57M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -3.53 | -8.47 | -14.61 | -11.88 | -9.69 | |||
Non GAAP EPS | -3.80 | -8.97 | -14.51 | -6.24 | -0.63 | |||
Statistics | ||||||||
Gross Profit Margin | 60.55% | 68.45% | 59.37% | 53.37% | 68.00% | |||
Profit Margin | -92.04% | -81.25% | -114.31% | -94.05% | -102.04% | |||
Operating Profit Margin | -165.53% | -164.76% | -268.76% | -260.21% | -206.73% |
All data in USD